24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Epitomee
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
23:12
“The initial results indicate a complete vote of no confidence in Netanyahu”: Eisenkot vows to replace PM
22:36
Israel faces political deadlock as Netanyahu and opposition set to struggle to form a government
22:03
Netanyahu’s Likud emerges as Israel’s largest party, but exit polls point to another political deadlock
21:08
Israel turnout surpasses entire 2022 election total with two hours left to vote
More stories
Buzz
Most popular
Daily
Weekly
1
Microsoft offers buyouts to 60,000 workers but says layoffs remain an option
2
Intel to acquire Israeli quantum startup Classiq for $2.3 billion
3
Intel’s $2.3 billion Classiq deal follows years of personal investment by Lip-Bu Tan
4
Classiq founders set to pocket up to $100 million each in Intel’s $2.3 billion deal
5
Palantir CEO says Israel is the "minor exception" in AI race dominated by U.S. and China
More news
Epitomee
4 stories about Epitomee
Epitomee surges 200% in two days on FDA approval for weight loss pill
16.09.24
|
Adiel Eithan Mustaki
Investors are hopeful, but the company must now face an uphill battle in a crowded market.
Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement
04.12.23
|
Adiel Eithan Mustaki
The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level
Weight loss pill success sparks stock surge at Epitomee Medical
04.09.23
|
Adiel Eithan Mustaki
The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway
Weight-Loss Pill Developer Epitomee Raises $8 Million
10.04.19
|
CTech
Epitomee develops an orally administered capsule that affects the stomach through mechanosensory stimulation, encouraging prolonged gastric emptying and giving patients the sensation of being full